|
Volumn 3, Issue 3, 2012, Pages 172-173
|
Drug discovery 2012 and beyond
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
ASTHMA;
CENTRAL NERVOUS SYSTEM DISEASE;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG RESEARCH;
DRUG SAFETY;
DRUG TARGETING;
ECONOMIC ASPECT;
FUNDING;
GASTROINTESTINAL DISEASE;
HIGH THROUGHPUT SCREENING;
HUMAN;
HYPERTENSION;
INTERDISCIPLINARY COMMUNICATION;
INTERPERSONAL COMMUNICATION;
MEDICAL EXPERT;
MEDICAL STAFF;
NOTE;
OSTEOPOROSIS;
PRIORITY JOURNAL;
PUBLIC-PRIVATE PARTNERSHIP;
SCIENTIST;
STRATEGIC PLANNING;
STRUCTURE ACTIVITY RELATION;
TEAMWORK;
TRANSLATIONAL RESEARCH;
UNIVERSITY HOSPITAL;
|
EID: 84858263542
PISSN: None
EISSN: 19485875
Source Type: Journal
DOI: 10.1021/ml300022p Document Type: Note |
Times cited : (5)
|
References (1)
|